{"pressReleaseArticle":{"contentWrapper":{"title":"GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025","intro":"","publishDateTime":"09/04/2025 00:00:00","publishDate":"April 09 2025","forInvestorsAndMediaOnlyText":"

Issued: Philadelphia, PA

\r\n

For media and investors only

","shortDescription":"GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education.","image":null,"downloadLink":{"text":"Download (PDF - 254.1KB)","href":"/media/ca2bs0aa/coimmunity-24-and-25-grant-announcement_final.pdf","title":"Opens in a new window","target":"_blank"},"tags":[]},"components":[{"type":"rich-text","text":"\n

GSK plc (LSE/NYSE: GSK) today announced the recipients of its COiMMUNITY Initiative grant program, awarding nearly $2 million to 15 regional, state and national non-profits and community-based groups working to boost adult immunization through improved vaccine education, outreach and access.

\n

Leonard Friedland, VP and Director, Scientific Affairs and Public Health, Vaccines, GSK, said: “We are committed to ensuring people have access to clear, trustworthy information about vaccines so that they can make the best decisions for themselves and their families. The 2024 COiMMUNITY Initiative grant recipients have designed vaccine education, outreach and access programs with the needs of their specific communities in mind. By offering educational tools to individuals and healthcare providers, these organizations are empowering people to take control of their preventive health and make informed choices about vaccination.”

\n

The 2024 COiMMUNITY Initiative grant recipients include Sepsis Alliance and Pennsylvania Pharmacists Association who complement one another’s efforts by approaching adult immunization gaps from different angles — from making the connection between vaccines and the prevention of a little-known but deadly illness to helping pharmacists make vaccination a year-round effort.

\n

Thomas Heymann, President and CEO, Sepsis Alliance, said: “Each year, sepsis kills more people than cancer. Since sepsis results from the body’s overreaction to an infection, vaccination could have potentially prevented many of these cases. This grant funding will help us spread the word about the value of vaccination for sepsis prevention through social media, web resources and PSAs on billboards and transit shelters in low-vaccination areas.”

\n

“Adult immunization rates tend to rise and fall with the seasons, even though most vaccines are not inherently seasonal. With GSK’s support, we are equipping pharmacies across the Commonwealth with the tools they need to encourage year-round vaccination so that we don't miss out on opportunities for protection, said Victoria Elliott, CEO, Pennsylvania Pharmacists Association (PPA). PPA’s COiMMUNITY grant efforts include education to assist in targeted year-round outreach and technology to identify eligible recipients and help track vaccinations.”

\n

Other awardees for 2024 are American Heart Association, American Lung Association, American Pharmacists Association, Asthma and Allergy Foundation of America, Autism Society, Ever Thrive Illinois, Global Healthy Living Foundation, Indiana Immunization Coalition, National Council on Aging, National Foundation for Infectious Diseases, Pharmacy Society of Wisconsin, Ryan Health and The Immunization Partnership.

\n

Call for 2025 COiMMUNITY Initiative Grant Proposals  

\n

This year, GSK will be awarding another $2 million in COiMMUNITY Initiative grants to support ambitious and actionable efforts to increase US adult immunization rates through vaccine education, outreach and access. Eligible organizations can submit a proposal through gskgrants.com. Please address your letter of request to the COiMMUNITY Initiative. GSK will review grant proposals on a rolling basis until mid-November of 2025.

\n

About the COiMMUNITY Initiative

\n

GSK’s COiMMUNITY Initiative aims to address long-standing barriers to adult immunization in the US through funding, increased data transparency and resource-sharing opportunities. Since the start of the COiMMUNITY Initiative grant program in 2023, GSK has awarded a total of $3 million to regional, state and national non-profits and community-based groups working to build awareness and access to adult vaccination across the US.

\n

About GSK   

\n

GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at gsk.com.

\n

Cautionary statement regarding forward-looking statements

\n

GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Such factors include, but are not limited to, those described under Item 3.D “Risk factors” in GSK’s Annual Report on Form 20-F for 2024. 

","useGreyBackground":false,"fullWidth":false},{"type":"varied-signpost-grid","title":"You might also like","layoutPattern":4,"pages":[{"title":"Media contacts","content":"Contact our GSK US Media Team. We are committed to responding to the information needs of the media as quickly as possible","image":{"src":"/media/k2xl0f3e/one-person-in-front-of-media-section-3.jpg?rxy=0.44833333333333331,0.94375&width=427&height=533&format=webp&quality=100&v=1dbe12268273820","alt":"men in front of media station ","darkModeSrc":"/media/k2xl0f3e/one-person-in-front-of-media-section-3.jpg?rxy=0.44833333333333331,0.94375&width=427&height=533&format=webp&quality=90&v=1dbe12268273820"},"link":{"text":"Media contacts","href":"/en-us/media/media-contacts/","openInNewWindowText":null}},{"title":"Company","content":"We unite science, technology and talent to get ahead of disease together","image":{"src":"/media/suilv4ve/dna-and-tech-science-image-rgb.jpg?width=427&height=533&format=webp&quality=100&v=1dcb546428b35f0","alt":"DNA And Tech Science Image","darkModeSrc":"/media/suilv4ve/dna-and-tech-science-image-rgb.jpg?width=427&height=533&format=webp&quality=90&v=1dcb546428b35f0"},"link":{"text":"Company","href":"/en-us/company/","openInNewWindowText":null}},{"title":"Press releases","content":"Keep up to date with our news and recent announcements","image":{"src":"/media/viygjccz/person-getting-interviewed-2.jpg?rxy=0.46666666666666667,0.69125&width=427&height=533&format=webp&quality=100&v=1dbe122680aaf70","alt":"two people on air.","darkModeSrc":"/media/viygjccz/person-getting-interviewed-2.jpg?rxy=0.46666666666666667,0.69125&width=427&height=533&format=webp&quality=90&v=1dbe122680aaf70"},"link":{"text":"Press releases","href":"/en-us/media/press-releases/","openInNewWindowText":null}}],"hidePageDescription":false,"useGreyBackground":false}]},"id":5219,"docCheckLogout":null,"pageType":"pressReleasePage","languageCode":"en-US","theme":"light","breadcrumb":{"ariaLabel":"Breadcrumb","links":[{"text":"Home","href":"/en-us/","openInNewWindowText":null},{"text":"Media","href":"/en-us/media/","openInNewWindowText":null},{"text":"Press releases","href":"/en-us/media/press-releases/","openInNewWindowText":null},{"text":"GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025","href":"/en-us/media/press-releases/gsk-awards-2m-in-grant-funding-for-programs-supporting-adult-vaccination-commits-additional-2m-for-2025/","openInNewWindowText":null}]},"pageName":"GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025","topNav":{"homeLink":{"text":"GSK Homepage","href":"/en-us/","openInNewWindowText":null},"topBar":{"currentLocation":{"isGlobal":false,"text":"United States (EN)"},"languageSelector":{"currentLanguage":null,"currentLanguageMobile":null,"selectableLanguages":[]},"darkModeSwitch":{"text":"Dark Mode","tooltipText":"

Switch to dark mode to head towards a more sustainable world together. More info

"},"globalSiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"locationSelector":{"text":"Change location","href":"/en-us/locations/","openInNewWindowText":null},"healthCareLink":{"text":"Healthcare professionals","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"contactUs":{"text":"Contact us","href":"/en-us/contact-us/","openInNewWindowText":null},"search":"Search","backToMain":"Back to main","menu":"Menu","closeMenu":"Close menu","animationsToggleModel":{"enable":true,"activeText":"Pause video","inactiveText":"Play video"}},"nodes":[{"tooltip":null,"hasBorderRight":true,"title":"Behind the Science US edition","url":"/en-us/behind-the-science-us-edition/","nodes":[],"isActive":false,"promos":[]},{"tooltip":null,"hasBorderRight":false,"title":"Company","url":"/en-us/company/","nodes":[{"title":"Purpose, strategy and culture","url":"/en-us/company/purpose-strategy-and-culture/","nodes":[],"isActive":false},{"title":"Respiratory, immunology and inflammation","url":"/en-us/company/respiratory-immunology-and-inflammation/","nodes":[],"isActive":false},{"title":"Oncology","url":"/en-us/company/oncology/","nodes":[{"title":"Myelofibrosis","url":"/en-us/company/oncology/myelofibrosis/","nodes":[],"isActive":false},{"title":"Ovarian cancer","url":"/en-us/company/oncology/ovarian-cancer/","nodes":[],"isActive":false},{"title":"Endometrial cancer","url":"/en-us/company/oncology/endometrial-cancer/","nodes":[],"isActive":false},{"title":"Multiple myeloma","url":"/en-us/company/oncology/multiple-myeloma/","nodes":[],"isActive":false},{"title":"Rectal cancer","url":"/en-us/company/oncology/rectal-cancer/","nodes":[],"isActive":false}],"isActive":false},{"title":"HIV","url":"/en-us/company/hiv/","nodes":[],"isActive":false},{"title":"Infectious diseases","url":"/en-us/company/infectious-diseases/","nodes":[{"title":"Vaccines","url":"/en-us/company/infectious-diseases/vaccines/","nodes":[],"isActive":false},{"title":"Flu","url":"/en-us/company/infectious-diseases/flu/","nodes":[],"isActive":false},{"title":"Shingles (Herpes Zoster)","url":"/en-us/company/infectious-diseases/shingles-herpes-zoster/","nodes":[],"isActive":false},{"title":"RSV (Respiratory Syncytial Virus)","url":"/en-us/company/infectious-diseases/rsv-respiratory-syncytial-virus/","nodes":[],"isActive":false},{"title":"Meningitis","url":"/en-us/company/infectious-diseases/meningitis/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Global Outstanding people","image":{"src":"/media/kjtduuwb/20250115-extra-6-phl-small.jpg?width=329&height=185&format=webp&quality=100&v=1dbe12238ee2370","alt":"Two people walking in an office","darkModeSrc":"/media/kjtduuwb/20250115-extra-6-phl-small.jpg?width=329&height=185&format=webp&quality=90&v=1dbe12238ee2370"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/outstanding-people/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global policy positions","image":{"src":"/media/diaofnw2/20250115-extra-14-phl.jpg?width=329&height=185&format=webp&quality=100&v=1dbe122233e8880","alt":"An employee attending an online meeting","darkModeSrc":"/media/diaofnw2/20250115-extra-14-phl.jpg?width=329&height=185&format=webp&quality=90&v=1dbe122233e8880"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/company/policy-positions","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Innovation","url":"/en-us/innovation/","nodes":[{"title":"Therapeutic areas","url":"/en-us/innovation/therapeutic-areas/","nodes":[],"isActive":false},{"title":"Technologies","url":"/en-us/innovation/technologies/","nodes":[],"isActive":false},{"title":"Clinical studies","url":"/en-us/innovation/clinical-studies/","nodes":[{"title":"Representative clinical trials","url":"/en-us/innovation/clinical-studies/representative-clinical-trials/","nodes":[],"isActive":false}],"isActive":false}],"isActive":false,"promos":[{"text":"Global pipeline","image":{"src":"/media/zr0acsx2/20281231-c1-innovation-um.jpg?width=329&height=185&format=webp&quality=100&v=1dc8fa7a9f728d0","alt":"A close-up shot of scientist's hands handling a vial","darkModeSrc":"/media/zr0acsx2/20281231-c1-innovation-um.jpg?width=329&height=185&format=webp&quality=90&v=1dc8fa7a9f728d0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/innovation/pipeline/","target":"_blank","openInNewWindowText":"Opens in a new window"}},{"text":"Global Behind the science magazine","image":{"src":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?width=329&height=185&format=webp&quality=100&v=1dcc04016a69c90","alt":"GSK Tech Human Image","darkModeSrc":"/media/vvwddvsg/gsk_tech_human_image_6k.jpg?width=329&height=185&format=webp&quality=90&v=1dcc04016a69c90"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/behind-the-science-magazine/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Products","url":"/en-us/products/","nodes":[],"isActive":false,"promos":[]},{"tooltip":null,"hasBorderRight":true,"title":"Responsibility","url":"/en-us/responsibility/","nodes":[{"title":"Inclusion","url":"/en-us/responsibility/inclusion/","nodes":[],"isActive":false},{"title":"US charitable investments","url":"/en-us/responsibility/us-charitable-investments/","nodes":[{"title":"Charitable grants","url":"/en-us/responsibility/us-charitable-investments/charitable-grants/","nodes":[],"isActive":false}],"isActive":false},{"title":"Ethical standards","url":"/en-us/responsibility/ethical-standards/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Access to medicines","image":{"src":"/media/q2cllvad/20271231-a1-careers-up.jpg?width=329&height=185&format=webp&quality=100&v=1dbe1221dd270f0","alt":"A scientist checking experiment results in the lab","darkModeSrc":"/media/q2cllvad/20271231-a1-careers-up.jpg?width=329&height=185&format=webp&quality=90&v=1dbe1221dd270f0"},"link":{"text":"FEATURED WEBSITE","href":"https://www.gskforyou.com/","openInNewWindowText":null}},{"text":"Global Responsibility ","image":{"src":"/media/e5nbvffs/20250115-f4-ethical-standards-um.jpg?width=329&height=185&format=webp&quality=100&v=1dbe1221ed9f5e0","alt":"A smiling scientist posing in the lab","darkModeSrc":"/media/e5nbvffs/20250115-f4-ethical-standards-um.jpg?width=329&height=185&format=webp&quality=90&v=1dbe1221ed9f5e0"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/responsibility/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Media","url":"/en-us/media/","nodes":[{"title":"Press releases","url":"/en-us/media/press-releases/","nodes":[],"isActive":true},{"title":"Media contacts","url":"/en-us/media/media-contacts/","nodes":[],"isActive":false},{"title":"In Focus","url":"/en-us/media/in-focus/","nodes":[{"title":"Flu is a Family Affair","url":"/en-us/media/in-focus/flu-is-a-family-affair/","nodes":[],"isActive":false},{"title":"Five for Five","url":"/en-us/media/in-focus/five-for-five/","nodes":[],"isActive":false}],"isActive":false}],"isActive":true,"promos":[{"text":"Global press releases","image":{"src":"/media/svplhxgn/20271231-h2-visit-our-global-careers-site-link-um.jpg?width=329&height=185&format=webp&quality=100&v=1dbe12238bed610","alt":"Two employees discussing work in the office","darkModeSrc":"/media/svplhxgn/20271231-h2-visit-our-global-careers-site-link-um.jpg?width=329&height=185&format=webp&quality=90&v=1dbe12238bed610"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/media/press-releases/","target":"_blank","openInNewWindowText":"Opens in a new window"}}]},{"tooltip":null,"hasBorderRight":false,"title":"Careers","url":"/en-us/careers/","nodes":[{"title":"Search jobs","url":"/en-us/careers/search-jobs/","nodes":[],"isActive":false},{"title":"Life at GSK","url":"/en-us/careers/life-at-gsk/","nodes":[{"title":"Employment rights under federal law","url":"/en-us/careers/life-at-gsk/employment-rights-under-federal-law/","nodes":[],"isActive":false}],"isActive":false},{"title":"Experienced professionals","url":"/en-us/careers/experienced-professionals/","nodes":[{"title":"A career in oncology","url":"/en-us/careers/experienced-professionals/a-career-in-oncology/","nodes":[],"isActive":false},{"title":"A career in Boston","url":"/en-us/careers/experienced-professionals/a-career-in-boston/","nodes":[],"isActive":false}],"isActive":false},{"title":"Early careers","url":"/en-us/careers/early-careers/","nodes":[{"title":"Apprentices","url":"/en-us/careers/early-careers/apprentices/","nodes":[],"isActive":false},{"title":"Internships and co-ops","url":"/en-us/careers/early-careers/internships-and-co-ops/","nodes":[],"isActive":false},{"title":"Scientific leadership program","url":"/en-us/careers/early-careers/scientific-leadership-program/","nodes":[],"isActive":false},{"title":"Commercial development program","url":"/en-us/careers/early-careers/commercial-development-program/","nodes":[],"isActive":false}],"isActive":false},{"title":"Veterans at GSK","url":"/en-us/careers/veterans-at-gsk/","nodes":[],"isActive":false}],"isActive":false,"promos":[{"text":"Global how we hire","image":{"src":"/media/3u2dneiw/20271231-a3-contact-us-phl.jpg?width=329&height=185&format=webp&quality=100&v=1dbe12236d41d10","alt":"Three employees meeting in the office","darkModeSrc":"/media/3u2dneiw/20271231-a3-contact-us-phl.jpg?width=329&height=185&format=webp&quality=90&v=1dbe12236d41d10"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/how-we-hire/","openInNewWindowText":null}},{"text":"Global graduate program","image":{"src":"/media/xrsfni0a/20281231-h4a-achieve-your-career-goals-up.jpg?width=329&height=185&format=webp&quality=100&v=1dbe1221e21c970","alt":"A smiling scientist posing in the lab","darkModeSrc":"/media/xrsfni0a/20281231-h4a-achieve-your-career-goals-up.jpg?width=329&height=185&format=webp&quality=90&v=1dbe1221e21c970"},"link":{"text":"Spotlight on","href":"https://www.gsk.com/en-gb/careers/early-talent/future-leaders-graduate-programme","openInNewWindowText":null}}]}],"skipToContent":null,"skipToSearch":null,"typeaheadSearch":{"apiEndpoint":"api/search/typeahead?siteContainerId=1702","searchFieldPlaceholderText":"Enter a search term...","searchPage":"/en-us/search/","ariaLabel":"Submit form"},"ariaLabel":"Global navigation"},"footer":{"logo":null,"copyrightText":"

This is our US website, intended for US audiences only. Other market sites can be reached by visiting our location selector.

\n

© 2001-2026 GSK plc. All rights reserved. Trade marks are owned by or licensed to the GSK group of companies.

\n

GSK plc. Registered in England and Wales No. 3888792.

\n

Registered office: 79 New Oxford Street, London. United Kingdom. WC1A 1DG

","modernSlaveryStatement":null,"sections":{"socialMedia":{"columnTitle":"Follow us on:","socialMediaItems":[{"globalLink":{"text":null,"href":"http://www.linkedin.com/company/glaxosmithkline","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on LinkedIn","customIcon":null,"showPopupMenu":false,"type":"LinkedIn"},{"globalLink":{"text":null,"href":"https://www.instagram.com/gskus?igsh=dDl0NjZmbmlia3F1","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Instagram","customIcon":null,"showPopupMenu":false,"type":"Instagram"},{"globalLink":{"text":null,"href":"https://www.threads.com/@gskus","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Threads","customIcon":null,"showPopupMenu":false,"type":"Threads"},{"globalLink":{"text":null,"href":"https://www.facebook.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Facebook","customIcon":null,"showPopupMenu":false,"type":"Facebook"},{"globalLink":{"text":null,"href":"http://www.youtube.com/GSK","target":"_blank","openInNewWindowText":"Opens in a new window"},"localLink":null,"ariaLabel":"Follow us on Youtube","customIcon":null,"showPopupMenu":false,"type":"Youtube"}]},"columns":[{"columnTitle":"GSK websites","links":[{"text":"GSK Global website","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Locations selector","href":"/en-us/locations/","openInNewWindowText":null},{"text":"Global Behind the science","href":"https://www.gsk.com/en-gb/behind-the-science/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSKPro for HCPs","href":"https://gskpro.com","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"ViiV Healthcare","href":"https://viivhealthcare.com/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"GSK study register","href":"https://www.gsk-studyregister.com/en/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Business to Business","href":"/en-us/business-to-business-in-the-us/","openInNewWindowText":null},{"text":"Supplier website","href":"https://supplier.gsk.com/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Quick links","links":[{"text":"Behind the science US edition","href":"/en-us/behind-the-science-us-edition/","openInNewWindowText":null},{"text":"Company","href":"/en-us/company/","openInNewWindowText":null},{"text":"Innovation","href":"/en-us/innovation/","openInNewWindowText":null},{"text":"Products","href":"/en-us/products/","openInNewWindowText":null},{"text":"Responsibility","href":"/en-us/responsibility/","openInNewWindowText":null},{"text":"Media","href":"/en-us/media/","openInNewWindowText":null},{"text":"Careers","href":"/en-us/careers/","openInNewWindowText":null}]},{"columnTitle":"Global investors","links":[{"text":"Shareholders","href":"https://www.gsk.com/en-gb/investors/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Quarterly results","href":"https://www.gsk.com/en-gb/investors/quarterly-results/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Financial reports","href":"https://www.gsk.com/en-gb/investors/financial-reports/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Share price analysis","href":"https://www.gsk.com/en-gb/investors/dividend-and-share-price/","openInNewWindowText":null},{"text":"Product pipeline","href":"https://www.gsk.com/en-gb/innovation/pipeline/","target":"_blank","openInNewWindowText":"Opens in a new window"}]},{"columnTitle":"Get in touch","links":[{"text":"Contact us","href":"/en-us/contact-us/","openInNewWindowText":null},{"text":"Report a possible side effect","href":"/en-us/report-a-possible-side-effect/","openInNewWindowText":null},{"text":"GSK Speak up","href":"https://www.gsk.com/speakup","target":"_blank","openInNewWindowText":"Opens in a new window"}]}]},"bottomLinks":[{"text":"Accessibility","href":"/en-us/accessibility/","openInNewWindowText":null},{"text":"Digital sustainability","href":"/en-us/digital-sustainability/","openInNewWindowText":null},{"text":"Terms of use","href":"/en-us/terms-of-use/","openInNewWindowText":null},{"text":"Cookie policy","href":"/en-us/cookie-policy/","openInNewWindowText":null},{"text":"Privacy notice","href":"https://privacy.gsk.com/en-us/privacy-notice/","target":"_blank","openInNewWindowText":"Opens in a new window"},{"text":"Sitemap","href":"/en-us/sitemap/","openInNewWindowText":null}],"continueToLink":null,"legalApprovalText":""},"sharing":{"description":"GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education.","og":[{"property":"og:title","content":"GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025"},{"property":"og:description","content":"GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education."},{"property":"og:image","content":"https://us.gsk.com/media/gdvhctix/scientist-testing-biological-samples.jpg?width=600&format=webp&quality=100&v=1dcc1f03f5ccb30"},{"property":"og:url","content":"https://us.gsk.com/en-us/media/press-releases/gsk-awards-2m-in-grant-funding-for-programs-supporting-adult-vaccination-commits-additional-2m-for-2025/"}],"twitter":[{"name":"twitter:card","content":"summary_large_image"},{"name":"twitter:site","content":"@gsk"},{"name":"twitter:title","content":"GSK awards $2M in grant funding for programs supporting adult vaccination, commits additional $2M for 2025"},{"name":"twitter:description","content":"GSK is funding public health organizations working to address US adult immunization gaps and increase community vaccine education."},{"name":"twitter:image","content":"https://us.gsk.com/media/gdvhctix/scientist-testing-biological-samples.jpg?width=600&format=webp&quality=100&v=1dcc1f03f5ccb30"},{"name":"twitter:url","content":"https://us.gsk.com/en-us/media/press-releases/gsk-awards-2m-in-grant-funding-for-programs-supporting-adult-vaccination-commits-additional-2m-for-2025"}]},"stickyShare":null,"exitSitePreferences":{"popupEnabled":true,"title":"You are leaving our website","texts":"

The information you are about to be referred to may not comply with the local regulatory requirements. Further information relevant to the local environment is available from the company or via the Product Information.

","continueText":"Continue","cancelText":"Cancel","exclusionUrls":["https://www.gsk.com","https://www.facebook.com/GSK","http://doingmoreintheus.gsk.com/en-us/map-regions/","https://www.gsk.com/en-gb","https://www.gsk.com/en-gb/investors/quarterly-results/","https://www.gsk.com/en-gb/about-us/vaccines/why-you-don-t-outgrow-vaccination/","https://www.gsk.com/en-gb/behind-the-science/patients-consumers/eggs-in-manufacturing/","https://innovation.gsk.com/","http://doingmoreintheus.gsk.com/en-us/map-regions/north-carolina/doing-more-on-moore-drive-in-the-research-triangle-park/","http://doingmoreintheus.gsk.com/en-us/map-regions/pennsylvania/gsk-navy-yard-where-we-do-more-with-less/","https://www.gsk.com/en-gb/about-us/save-the-children-partnership","https://www.gskgrants.com","https://www.gskforyou.com/","http://fortherecord.payments.us.gsk.com","https://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","http://www.gsk.com/en-gb/about-us/policies-codes-and-standards/","https://www.gsk.com/en-gb/products/stiefel-dermatology/","https://www.gsk.com/en-gb/products/viiv-healthcare/","https://www.contactus.gsk.com/callback/index.html","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsksource.com/pharma/content/gsk/source/us/en.html","http://www.msds-gsk.com/","https://www.gsk.com/en-gb/investors/shareholder-information/","http://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/investors/corporate-reporting/","https://www.gsk.com/en-gb/investors/product-pipeline/","http://www.gskgrants.com/","https://www.gsksource.com/gskprm/en/US/adirect/gskprm?cmd=Home&entryPoint=adirect&messageType=Home","https://www.gsk.com/media/2941/human-rights-statement-policy.pdf","http://www.gsk.com/media/280848/human-rights-statement-policy.pdf","http://www.gsk.com/en-gb/research/rd-locations/pharmaceuticals/","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://www.gsk.com/en-gb/business-to-business/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","http://twitter.com/GSK","http://www.youtube.com/GSK","http://www.flickr.com/photos/glaxosmithkline","http://www.linkedin.com/company/glaxosmithkline","https://www.instagram.com/gsk/ ","http://www.gsk-clinicalstudyregister.com/","https://www.gsk.com/en-gb/media/press-releases/new-multi-country-survey-reveals-need-for-improved-awareness-around-long-term-impact-and-appropriate-use-of-corticosteroids-in-sle-management/","https://www.gsk.com/en-gb/behind-the-science/our-people/from-tv-to-tackling-lupus-why-alex-moved-from-media-to-medicine/","http://www.gskforyou.com/","http://us.gsk.com/en-us/behind-the-science/?tag=Corporate+responsibility","https://www.gskforyou.com/prescription-resource-assistance/immunology-respiratory/","https://www.contactus.gsk.com/callback.html","https://www.gsk.com/en-gb/about-us/governance/global-compliance/","https://www.gsk.com/en-gb/careers/physicians/","https://www.gsk.com/en-gb/careers/job-finder/","https://www.gsk.com/en-gb/contact-us/worldwide/","https://access.gsk.com/password/","https://access.gsk.com/selfservice/static/login.jsp?TYPE=33554433&REALMOID=06-c7edf5ec-5585-100d-83b1-84797f88fc89&GUID=&SMAUTHREASON=0&METHOD=GET&SMAGENTNAME=-SM-90R5K5a0NsTyKRhPyTIn3A3B5ovKkqcehflGRUrUNusjZdRaPY%2bWUozEFizs1bMg&TARGET=-SM-https%3a%2f%2fuksah%2egsk%2ecom%2fswh_uk_win_ns%2fcommunications%2femployee%2femployees%2ehtm","https://www.gsk.com/en-gb/responsibility/operating-responsibly/working-with-third-parties/","https://supplier.gsk.com/irj/portal/public?guest_user=SUP_GUEST_EN","https://ascend.cvmsolutions.com/Account/Login?client=gsk","https://twitter.com/GSKUS","https://twitter.com/GSK","https://www.gsk.com/media/5097/our-approach-to-responsible-business_sept-18.pdf","https://www.gsk.com/en-gb/responsibility/responsibility-reports-data/","https://www.gsk.com/media/2538/gsk-materiality-process.pdf","https://www.gsk.com/en-gb/responsibility/access-to-healthcare/","https://www.gsk.com/en-gb/responsibility/our-people/","https://www.gsk.com/en-gb/responsibility/environment/","https://www.gsk.com/en-gb/responsibility/operating-responsibly/","https://www.gsk.com/media/4552/our-code-of-practice.pdf","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=10","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.gsk.com/media/4552/our-code-of-practice.pdf#page=35","https://www.instagram.com/gsk/","https://twitter.com/gsk","https://twitter.com/gskus","https://www.youtube.com/GSK","https://www.gsk.com/en-gb/media/resource-centre/","https://www.gsk.com/en-gb/media/image-and-video-library/","https://www.gsk.com/en-gb/media/rss-feeds/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2017/","https://www.gsk.com/en-gb/careers/experienced-professionals/business-operations/","https://www.gsk.com/en-gb/careers/experienced-professionals/engineering/","https://www.gsk.com/en-gb/careers/experienced-professionals/manufacturing-and-supply/","https://www.gsk.com/en-gb/careers/experienced-professionals/marketing-and-communications/","https://www.gsk.com/en-gb/careers/experienced-professionals/research-and-development/","https://www.gsk.com/en-gb/careers/experienced-professionals/sales/","https://www.gsk.com/media/5041/rd-update-slides-hal-barron.pdf","https://www.gsk.com/en-gb/careers/meet-our-people/","https://www.gsk.com/en-gb/responsibility/our-people/employee-volunteering/","https://www.gsk.com/en-gb/careers/postgraduate-opportunities/","https://gskearlytalent.avature.net/landingpage","https://www.gsk.com/en-gb/careers/apprentices-students-and-graduates/future-leaders-graduate-programme/","https://www.gsk.com/en-gb/responsibility/our-people/volunteer-stories/","https://www.gsk.com/en-gb/partnerships/bioelectronics-research-network/","https://www.gsk.com/en-gb/research/our-approach/open-innovation/","https://www.gsk.com/en-gb/careers/careers-search/?r=USA","https://www.linkedin.com/company/gsk-canada/","https://www.linkedin.com/company/gsk_consumer_healthcare_india/","https://www.linkedin.com/company/gsk-pharmaceuticals-india/","https://www.linkedin.com/company/glaxosmithkline-poland/","https://www.youtube.com/user/gskasiachannel/","https://www.youtube.com/channel/UChWuz9ZDceHYHXmJVJ4hF8Q","https://www.youtube.com/channel/UCN1XeWQWLVhFLHQwZl93jFQ","https://www.youtube.com/channel/UCwQyIfV4pLlsZGuN7fiZm2w","https://twitter.com/gsk_ar","https://twitter.com/GSK_Asia","https://twitter.com/gsk_conferences","https://twitter.com/gsk_au","https://twitter.com/GSK_DE","https://twitter.com/GSKCH_INDIA","https://twitter.com/GSK_IE","https://twitter.com/gsk_it","https://twitter.com/GSKScience","https://twitter.com/stiefel","https://www.gsk.com/en-gb/media/press-releases/karenann-terrell-appointed-chief-digital-technology-officer-gsk/","https://www.gsk.com/en-gb/behind-the-science/innovation/the-digitalisation-lab-bringing-the-digital-age-to-manufacturing/","https://www.gsk.com/en-gb/careers/meet-our-people/lindsay-rd-uk/","http://uk.gsk.com/en-gb/careers/apprenticeships/","https://www.gsk.com/media/4931/gsk-quick-facts.pdf","https://ie.gsk.com/ie/careers/apprenticeships/","http://au.gsk.com/en-au/careers/apprenticeships/","http://sg.gsk.com/en-sg/careers/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/","https://gsk.i-sight.com/landing-page/","https://www.gskforyou.com/","https://jobs.gsk.com/en-us/jobs?keywords=RichmondConsumerHealthcareR%26D&page=1","https://jobs.gsk.com/en-us/jobs?page=1&location=Lincoln,%20NE,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=Carlisle,%20PA,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://jobs.gsk.com/en-us/jobs?page=1&location=East%20Durham,%20NY,%20United%20States&woe=7&stretch=10&stretchUnit=KILOMETERS&keywords=manufacturing&sortBy=relevance","https://us.gsk.com/en-us/media/press-releases/fda-approves-parp-inhibitor-in-first-line-monotherapy-maintenance-treatment-for-women-with-platinum-responsive-advanced-ovarian-cancer-regardless-of-biomarker-status/","https://privacy.gsk.com/en-us/privacy-notice/","https://www.gsk.com/en-gb/investors/corporate-reporting/annual-report-2020/","https://www.gsk.com/en-gb/careers/","https://www.gsk.com/en-gb/media/press-releases/gsk-delivers-fy-2021-reported-sales-of-34-billion-stable-at-aer-plus5-cer/","https://www.gsk.com/en-gb/investors/financial-reports/annual-report-2021/","https://www.gsk.com/media/7473/esg-performance-report-2021.pdf","https://www.gsk.com/en-gb/company/codes-standards-and-reports/","https://www.gsk.com/en-gb/investors/","https://www.gsk.com/en-gb/media/our-response-to-covid-19/","https://www.gsk.com/en-gb/behind-the-science-magazine/","https://www.gsk.com/en-gb/media/","https://www.gsk.com/en-gb/behind-the-science/","https://gskpro.com/","https://viivhealthcare.com/","https://www.gsk-studyregister.com/en/","https://gsk.supplierone.co/","https://www.gsk.com/en-gb/investors/financial-reports/","https://www.gsk.com/en-gb/investors/dividend-and-share-price/","https://www.gsk.com/en-gb/innovation/pipeline/","https://www.gsk.com/speakup","https://www.gsk.com/en-gb/company/outstanding-people/","https://www.gsk.com/en-gb/company/policy-positions","https://www.gsk.com/en-gb/research-and-development/our-approach-to-rd/","https://www.gsk.com/en-gb/innovation/partnerships/","https://www.gsk.com/media/8519/the-code-printable-version.pdf","https://www.gsk.com/en-gb/company/policy-positions/#","https://www.gsk.com/en-gb/innovation/therapeutic-areas/infectious-diseases/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/hiv/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/oncology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/immunology/","https://www.gsk.com/en-gb/innovation/therapeutic-areas/opportunity-driven/","https://www.togetherwithgskoncology.com/","https://www.gsk.com/en-gb/behind-the-science/looking-deeper-into-lupus/","https://gateway.on24.com/wcc/eh/3471076/Patient+Engagement+Hub","https://www.gsk.com/en-gb/behind-the-science/following-the-science-of-oxygen-to-discover-solutions-for-anaemia/","https://www.multivu.com/players/English/8857131-gsk-ask2bsure-meningitis-b-vaccination/","https://www.gsk.com/en-gb/innovation/rd-locations/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/innovation/research-and-development-approach/","https://www.gsk.com/en-gb/innovation/","https://www.gsk.com/en-gb/behind-the-science/mrna-messenger-ribonucleic-acid-disrupting-the-field-of-vaccinology/","https://www.gsk.com/en-gb/behind-the-science/inside-the-vaccine-factory-of-the-future/","https://www.gsk-studyregister.com/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/pricing-and-access/","https://www.gsk.com/en-gb/responsibility/global-health-and-health-security/","https://www.gsk.com/en-gb/responsibility/diversity-equity-and-inclusion/","https://www.gsk.com/en-gb/responsibility/environmental-sustainability/","https://www.gsk.com/en-gb/responsibility/product-governance/","https://www.gsk.com/en-gb/responsibility/ethical-standards/","https://www.gsk.com/media/8518/policies-and-standards.pdf","https://www.gsk.com/en-gb/company/governance/compliance/","https://www.gsk.com/en-gb/responsibility/ethical-standards/working-with-third-parties/","https://www.gsk.com/en-gb/responsibility/ethical-standards/public-policy-and-patient-advocacy/","https://www.gsk.com/en-gb/responsibility/ethical-standards/human-rights/","https://www.gsk.com/en-gb/responsibility/ethical-standards/use-of-animals/","https://www.gsk.com/en-gb/responsibility/ethical-standards/engaging-with-healthcare-professionals/","https://www.gsk.com/en-gb/media/press-releases/","https://annualreport.gsk.com/","https://www.gsk.com/en-gb/media/media-contacts/","https://www.gsk.com/en-gb/media/media-library/","https://www.gsk.com/en-gb/media/social-media/","https://www.gsk.com/en-gb/media/our-response-to-the-situation-in-ukraine/","https://jobs.gsk.com/en-us/jobs?keywords=%23ApprenticeUS&location=&lang=en-us","https://www.gsk.com/en-gb/behind-the-science/advancing-the-next-generation-of-immuno-oncology/","https://www.gsk.com/en-gb/behind-the-science/synthetic-lethality-outmanoeuvring-the-cancer-genome/","https://www.gsk.com/en-gb/media/press-releases/gsk-and-lyell-immunopharma-join-forces-to-develop-the-next-generation-of-cancer-cell-therapies/","https://jobs.gsk.com/en-us/jobs?keywords=oncology&page=1","https://jobs.gsk.com/en-us/jobs?keywords=oncology&page=1","https://www.gsk.com/en-gb/research-and-development/our-pipeline/","https://jobs.gsk.com/en-us/jobs?keywords=%23WYARD2022&location=&lang=en-us","https://jobs.gsk.com/en-us/jobs?keywords=%23WYAcommerical2022&lang=en-us&sortBy=relevance&page=1","https://jobs.gsk.com/en-us/jobs?keywords=%23WYAGSC2022&lang=en-us&sortBy=relevance&page=1","https://jobs.gsk.com/en-us/jobs?lang=en-us&sortBy=relevance&page=1&location=United%20States&woe=12&stretchUnit=MILES&stretch=10","https://www.gsk.com/media/8520/the-code-presentation-version.pdf","https://www.gsk.com/en-gb/careers/featured-careers/","https://www.gsk.com/en-gb/careers/how-we-hire/","https://www.gsk.com/en-gb/careers/our-global-and-regional-hubs/","https://www.gsk.com/en-gb/careers/how-we-hire/frequently-asked-questions/","https://supplier.gsk.com/irj/portal/public","http://www.gsk.com/en-gb/contact-us/worldwide/","https://www.gsk.com/en-gb/contact-us/report-a-possible-side-effect/enquiries-privacy-notice/","https://gskpro.com/en-us/","https://gskpro.com/","https://gskpro.com","https://www.gsk.com/en-gb/responsibility/esg-resources/","http://www.gskfunding.com/","https://www.gsk.com/en-gb/behind-the-science-magazine/prevention-best-medicine-disease-patients/","https://www.gsk.com/en-gb/behind-the-science-magazine/men-women-gender-diversity-clinical-trials/","https://www.gsk.com/en-gb/behind-the-science-magazine/maps-technology-new-age-vaccine-development-infectious-diseases/","https://www.gsk.com/en-gb/investors/speeches-and-presentations/","https://www.gsk.com/en-gb/responsibility/environment/climate/","https://contactus.gsk.com/","https://gsk.connectr.co.uk/getahead/","https://www.linkedin.com/company/gsk/","https://x.com/GSKUS?mx=2","https://www.facebook.com/GSK/","https://jobs.gsk.com/?lang=en-us&previousLocale=en-US","https://jobs.gsk.com/en-us/jobs?keywords=%23USCommercialDevelopmentProgram&page=1&sortBy=relevance?keywords=%23USCommercialDevelopmentProgram&page=1&sortBy=relevance&location=United%20States","https://jobs.gsk.com/?lang=en-us&previousLocale=en-US","https://jobs.gsk.com/en-us/jobs?keywords=&location=&lang=en-us?keywords=%23ApprenticeUS2026&page=1&sortBy=relevance&location=United%20States&stretch=10&stretchUnit=MILES?keywords=%23ApprenticeUS2025%20&page=1&sortBy=relevance&location=United%20States","https://www.vaccinetrack.com/Trend?tab=gap&vaccine=9&timePeriod=2021","https://jobs.gsk.com/en-us/jobs?keywords=&location=&lang=en-us","http://tinyurl.com/mrt9buj2","https://jobs.gsk.com/en-gb/jobs?location=Massachusetts,%20United%20States&locations=Boston,Massachusetts,United%20States%7CCambridge,Massachusetts,United%20States%7CWaltham,Massachusetts,United%20States&page=1&stretch=10&stretchUnit=MILES&woe=8","https://jobs.gsk.com/en-us/jobs?keywords=%23USCommercialDevelopmentProgram&sortBy=relevance&page=1&location=United%20States&woe=12®ionCode=US&stretchUnit=MILES&stretch=50","https://jobs.gsk.com/en-us/jobs?keywords=%23USCommercialDevelopmentProgram&page=1&sortBy=relevance&location=United%20States?keywords=%23ApprenticeUS&location=&lang=en-us","https://x.com/GSKUS","https://ourwayforward.com/content/dam/brs-pharma-us/ourwayforward-dtc/en_US/pdfs/oc-patient-discussion-guide.pdf","https://gsk.public.reportum.com/","https://password.gsk.com/password/","https://uksah.gsk.com/swh_uk_win_ns/communications/employee/employees.htm","https://www.vaccinetrack.com/Trend?tab=gap&timePeriod=2022&timePeriod2=2021","https://gskvaccination.com/","https://jobs.gsk.com/en-gb/jobs?lang=en-gb&page=1&location=Massachusetts,%20United%20States&woe=8&stretchUnit=MILES&stretch=10&locations=Boston,Massachusetts,United%20States%7CCambridge,Massachusetts,United%20States%7CWaltham,Massachusetts,United%20States&utm_source=direct&utm_campaign=25453&utm_medium=symphonytalent-misctags&utm_term=43516_Boston%20In-House","https://dontbeembarrassed.com/","https://www.vaccinetrack.com","https://scienceinthesummer.fi.edu/","https://jobs.gsk.com/en-gb/jobs?location=United%20States&locations=Boston,Massachusetts,United%20States%7CCambridge,Massachusetts,United%20States%7CWaltham,Massachusetts,United%20States&page=1&stretch=10&stretchUnit=MILES&woe=8"]},"settings":{"optionalStylesheetLink":null,"themeColorHexCode":null,"headerLogoLightTheme":null,"headerLogoDarkTheme":null,"footerLogo":{"src":"https://us.gsk.com/media/kzafk31i/gsk-logo.png?width=104&format=webp&quality=100&v=1dbe12293a58ec0","alt":"Gsk Logo (1)","darkModeSrc":"https://us.gsk.com/media/kzafk31i/gsk-logo.png?width=104&format=webp&quality=90&v=1dbe12293a58ec0"},"scripts":[{"pageLocation":"Top","text":" \n"}],"globalWebsiteLink":{"text":"Global","href":"https://www.gsk.com","target":"_blank","openInNewWindowText":"Opens in a new window"},"googleMapsApiKey":"AIzaSyA2QMg4Ww6djPKb7b9BraQn4kgJmDaLblg","textToSpeechApiKey":"70ab0a79-1d92-4286-86d2-abdd71cc785c","bingVerificationCode":"","googleAnalytics":"","siteTitle":" | GSK US"},"pageSettings":{"disableBackToTopButton":false,"backToTopButtonText":"Back to top","robotsNoFollow":false,"robotsNoIndex":false,"canonicalUrl":"https://us.gsk.com/en-us/media/press-releases/gsk-awards-2m-in-grant-funding-for-programs-supporting-adult-vaccination-commits-additional-2m-for-2025/"},"tealiumSettings":{"enabled":false,"data":""},"entryPopup":null,"protectedPage":false,"schema":null}